Illumina Applies CE Mark to MiSeqDx™ Cystic Fibrosis System: Omixon Target is Featured!
We have amazing news today as the first CE mark for next generation sequencing-based molecular diagnostics was just announced. Illumina applied CE mark to MiSeqDx™ Cystic Fibrosis System and Omixon Target is used for analyzing CFTR gene in prenatal labs! An excerpt from the announcement relevant to Omixon Target: Cystic...